Davis v. Zantac Maker of Ranitidine

CourtDistrict Court, S.D. Texas
DecidedMay 31, 2023
Docket4:22-cv-04116
StatusUnknown

This text of Davis v. Zantac Maker of Ranitidine (Davis v. Zantac Maker of Ranitidine) is published on Counsel Stack Legal Research, covering District Court, S.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Davis v. Zantac Maker of Ranitidine, (S.D. Tex. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT May 31, 2023 FOR THE SOUTHERN DISTRICT OF TEXAS Nathan Ochsner, Clerk HOUSTON DIVISION

TERRENCE L. DAVIS a/k/a TERRANCE L. § DAVIS, TDCJ # 01972854, § § Plaintiff, § § VS. § CIVIL ACTION NO. 4:22-4116 § ZANTAC MAKER OF RANITIDINE, et al., § § Defendants. §

MEMORANDUM OPINION AND ORDER

Plaintiff Terrence L. Davis, also known as Terrance L. Davis,1 is an inmate in the Texas Department of Criminal Justice–Correctional Institutions Division (TDCJ). Davis proceeds in forma pauperis in this civil rights action. Because this case is governed by the Prisoner Litigation Reform Act (PLRA), the Court is required to scrutinize the pleadings and dismiss the complaint in whole or in part if it is frivolous, malicious, or fails to state a claim upon which relief may be granted. 28 U.S.C. § 1915(e)(2)(B). After reviewing all of the pleadings as required, the Court concludes that this case must be DISMISSED for the reasons explained below. I. BACKGROUND

Davis executed his complaint in this action on November 9, 2022. He brings claims against two defendants: (1) “Zantac maker of ranitidine”; and (2) “TDCJ medical staff”

1 In his pleadings, Davis provides his first name as “Terrence.” However, TDCJ records for a prisoner with the same number show his name as “Terrance.” (Dkt. 1, at 3). He states that during his incarceration, TDCJ’s medical staff prescribed him Zantac, or ranitidine, for heartburn and acid reflux. He provides the dates of his prescriptions as December 19, 2011 through July 31, 2012, and January 24, 2015 through

“at least” April 24, 2020. He claims that, in October 2022, he learned while watching television that “this drug was causing cancer” (id. at 4). He alleges that he was “deliberately exposed” to Zantac and the cancer risk and complains that “[t]his company made million[s] of dollars of people and other company[ies] that bought” Zantac (id.). Davis submits medical reports reflecting that he was prescribed ranitidine while in

TDCJ (id. at 6-7). He also submits a copy of his request for information, dated October 13, 2022, asking why inmates had not been notified about the cancer risk from ranitidine or tested for cancer. The official who responded to Davis’ request stated that TDCJ had discontinued the frequent use of Zantac “immediately after reports were received,” and that “[n]o testing is indicated unless symptoms of possible cancer exist” (id. at 8-9).

Additionally, Davis submits his administrative grievance about the cancer risk from Zantac, dated October 27, 2022, which was not processed based on an official’s conclusion that the time to file a grievance had expired (id. at 10-11). Davis alleges that Zantac or its manufacturer was deliberately indifferent to the “substantial risk of serious harm” from exposure to “cancer causing substances,” in

violation of his constitutional rights (id. at 3). He alleges that TDCJ medical staff are liable because they did not give notice “to all inmates” that the drug they prescribed “was causing cancer,” thus placing his health and safety at risk (id. at 4). As relief for his claims, he seeks monetary damages and an “injunction for TDCJ-medical staff,” among other relief (id. at 5). II. THE PLRA AND PRO SE PLEADINGS

Because the plaintiff is a prisoner proceeding in forma pauperis, the Court is required by the PLRA to screen the case and dismiss the complaint at any time if it determines that the complaint is frivolous, malicious, fails to state a claim upon which relief may be granted, or seeks monetary relief against a defendant who is immune from such relief. 28 U.S.C. § 1915(e)(2)(B). A district court may dismiss a claim as frivolous if it

lacks any arguable basis in law or fact. Samford v. Dretke, 562 F.3d 674, 678 (5th Cir. 2009). A claim lacks an arguable basis in law “if it is based on an indisputably meritless legal theory.” Rogers v. Boatright, 709 F.3d 403, 407 (5th Cir. 2013) (cleaned up). It lacks an arguable basis in fact “if, after providing the plaintiff the opportunity to present additional facts when necessary, the facts alleged are clearly baseless.” Id. (cleaned up).

A dismissal for failure to state a claim is governed by the same standard as a motion to dismiss under Rule 12(b)(6) of the Federal Rules of Civil Procedure. See Newsome v. EEOC, 301 F.3d 227, 231 (5th Cir. 2002). Under this standard, the Court “construes the complaint liberally in favor of the plaintiff,” “takes all facts pleaded in the complaint as true,” and considers whether “with every doubt resolved on [the plaintiff’s] behalf, the

complaint states any valid claim for relief.” Harrington v. State Farm Fire & Cas. Co., 563 F.3d 141, 147 (5th Cir. 2009) (cleaned up). Additionally, a court must dismiss an action at any time if it determines that it lacks subject matter jurisdiction. FED. R. CIV. P. 12(h)(3). “A case is properly dismissed for lack of subject-matter jurisdiction when the court lacks the statutory or constitutional power to adjudicate the case.” Smith v. Regional Transit Auth., 756 F.3d 340, 347 (5th Cir. 2014) (cleaned up). Dismissal for lack of subject matter jurisdiction is warranted only if it

appears certain that the plaintiff cannot prove a plausible set of facts that establish jurisdiction. Venable v. La. Workers’ Comp. Corp., 740 F.3d 937, 941 (5th Cir. 2013). The Court must “take the well-pled factual allegations of the complaint as true and view them in the light most favorable to the plaintiff.” In re Mirant Corp, 675 F.3d 530, 533 (5th Cir. 2012).

In reviewing the pleadings, the Court is mindful of the fact that the plaintiff proceeds pro se. Complaints filed by pro se litigants are entitled to a liberal construction and, “however inartfully pleaded, must be held to less stringent standards than formal pleadings drafted by lawyers.” Erickson v. Pardus, 551 U.S. 89, 94 (2007) (cleaned up). Even under this lenient standard a pro se plaintiff must allege more than “‘labels and conclusions’ or a

‘formulaic recitation of the elements of a cause of action.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 555 (2007)); see Patrick v. Wal-Mart, Inc., 681 F.3d 614, 617 (5th Cir. 2012). “Threadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice.” Iqbal, 556 U.S. at 678 . Additionally, regardless of how well-pleaded the factual allegations may be,

they must demonstrate that the plaintiff is entitled to relief under a valid legal theory. See Neitzke v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Townsend v. Moya
291 F.3d 859 (Fifth Circuit, 2002)
Newsome v. EEOC
301 F.3d 227 (Fifth Circuit, 2002)
Geiger v. Jowers
404 F.3d 371 (Fifth Circuit, 2005)
Easter v. Powell
467 F.3d 459 (Fifth Circuit, 2006)
Samford v. Dretke
562 F.3d 674 (Fifth Circuit, 2009)
Harrington v. State Farm Fire & Casualty Co.
563 F.3d 141 (Fifth Circuit, 2009)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Neitzke v. Williams
490 U.S. 319 (Supreme Court, 1989)
Hein v. Freedom From Religion Foundation, Inc.
551 U.S. 587 (Supreme Court, 2007)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Teresa Patrick v. Wal-Mart, Incorporated
681 F.3d 614 (Fifth Circuit, 2012)
Bruce Rogers v. Shawna Boatright
709 F.3d 403 (Fifth Circuit, 2013)
Clapper v. Amnesty International USA
133 S. Ct. 1138 (Supreme Court, 2013)
Venable v. Louisiana Workers' Compensation Corp.
740 F.3d 937 (Fifth Circuit, 2013)
Mary Smith v. Regional Transit Authority, e
756 F.3d 340 (Fifth Circuit, 2014)
Ramona Hinojosa v. Brad Livingston
807 F.3d 657 (Fifth Circuit, 2015)
Pratt Ex Rel. Estate of Pratt v. Harris County
822 F.3d 174 (Fifth Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Davis v. Zantac Maker of Ranitidine, Counsel Stack Legal Research, https://law.counselstack.com/opinion/davis-v-zantac-maker-of-ranitidine-txsd-2023.